Quotient Limited Announces Proposed Underwritten Offering of Ordinary Shares
28 juil. 2016 16h10 HE
|
Quotient Limited
JERSEY, Channel Islands, July 28, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that it intends to commence an underwritten...
Quotient Limited Provides Update on the MosaiQ™ Development Plan and Reports Preliminary Fiscal First Quarter 2017 Revenues
11 juil. 2016 16h15 HE
|
Quotient Limited
Manufacturing system for MosaiQ™ consumables meeting design expectationsField trial instruments successfully pass rigorous internal evaluationMinor manufacturing facility modification recently...
Quotient Limited to Participate in Jefferies 2016 Global Healthcare Conference
31 mai 2016 08h30 HE
|
Quotient Limited
JERSEY, Channel Islands, May 31, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the company’s Chairman & CEO, Paul Cowan,...
Quotient Limited Reports Continued Progress on the Development of MosaiQ™ and Fourth Quarter and Fiscal Year 2016 Financial Results
23 mai 2016 16h17 HE
|
Quotient Limited
Completed commissioning of initial manufacturing system for MosaiQTM consumablesFirst field trial instruments received for internal evaluation and validationGenerated positive study results for...
Quotient Limited to Report Fourth Quarter Fiscal 2016 Financial Results and Host Conference Call
11 mai 2016 08h02 HE
|
Quotient Limited
JERSEY, Channel Islands, May 11, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fourth...
Quotient Limited to Participate in UBS Global Healthcare Conference
11 mai 2016 08h00 HE
|
Quotient Limited
JERSEY, Channel Islands, May 11, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the company’s Chairman & CEO, Paul Cowan,...
Quotient Awarded Group Purchasing Contract with Premier, Inc. for Blood Bank Reagents
21 avr. 2016 08h22 HE
|
Quotient Limited
JERSEY, Channel Islands, April 21, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that its U.S. subsidiary, Quotient...
Quotient Limited Announces Positive MosaiQ™ Serological Disease Screening Results
13 avr. 2016 16h06 HE
|
Quotient Limited
JERSEY, Channel Islands, April 13, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that results generated using the MosaiQTM...
Quotient Limited Announces Achievement of Major MosaiQ™ Project Milestones and Preliminary Fiscal Fourth Quarter 2016 Financial Results
13 avr. 2016 16h05 HE
|
Quotient Limited
Initial Manufacturing System for MosaiQ™ Consumables Successfully CommissionedFirst MosaiQ™ Field Trial Instruments Built and Received for Internal Evaluation JERSEY, Channel Islands, April 13,...
Quotient Limited Reports Third Quarter Fiscal 2016 Financial Results
08 févr. 2016 07h45 HE
|
Quotient Limited
Considerable progress on development and commercial scale-up of MosaiQ™, Quotient’s next-generation automation platform for transfusion diagnosticsMarketing of MosaiQ™ expected to start in the...